Antipsychotic (AP) medications are associated with an increased risk of developing
metabolic side effects including weight gain, type 2 diabetes (T2D), dyslipidemia, and …

Antipsychotic (AP) medications are associated with an increased risk for developing
metabolic side effects including weight gain, dyslipidemia, hypertension, type 2 diabetes …

Key points Mice are commonly housed at room temperatures below their thermoneutral
zone meaning they are exposed to chronic thermal stress. Endurance exercise induces …

Antipsychotic (AP) medications, such as olanzapine (OLZ), are used in the treatment of
schizophrenia and a growing number of 'off‐label'conditions. A single dose of OLZ causes …

Obesity can lead to impairments in hepatic glucose and insulin homeostasis, and although
exercise is an effective treatment, the molecular targets remain incompletely understood. As …

Olanzapine is a second-generation antipsychotic (SGA) used in the treatment of
schizophrenia and a number of off-label conditions. Although effective in reducing …

Combining physical and cognitive training has been suggested to promote further benefits
on brain and cognition, which could include synergistic improvement of hippocampal …

Olanzapine (OLZ) is a second‐generation antipsychotic that is used to treat schizophrenia
but also causes acute hyperglycemia. This study aimed to determine if the ablation of AMPK …

Exercise has been shown to be beneficial for individuals with Alzheimer's disease (AD). In
rodent models of AD, exercise decreases the amyloidogenic processing of the amyloid …

Second generation antipsychotics, particularly olanzapine, induce severe obesity, which is
associated with their antagonistic effect on the histamine H1 receptor (H1R). We have …